Repertoire Genesis
About:
Repertoire Genesis is a biotechnology company that provides new diagnostic methods development and neoepitope analysis services.
Website: https://www.repertoire.co.jp
Twitter/X: RepertGenesis
Top Investors: Beyond Next Ventures, UTEC - The University of Tokyo Edge Capital Partners, Zenyaku Kogyo
Description:
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.
Total Funding Amount:
1.8B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Osaka, Osaka, Japan
Founded Date:
2014-10-01
Founders:
Ryuji Suzuki
Number of Employees:
1-10
Last Funding Date:
2019-09-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai